Qirui Weishu capsules | China Drugs List

Public reference information, not medical advice, a prescription or an offer to supply a medicine. Confirm current approval, availability and suitability with licensed professionals.

Medicine type: Traditional Chinese medicine
Therapeutic area: Anesthesia & pain
Indications recorded in the public source: TCM actions: invigorates blood, resolves blood stasis, dries dampness and relieves pain. For epigastric pain due to mild-to-moderate chronic non-atrophic gastritis with erosions and the TCM pattern of damp-heat and blood-stasis obstruction. Associated findings include a dark-purple tongue or stasis spots, a yellow-greasy tongue coating, and a wiry-choppy or wiry-slippery pulse.
Indication source and scope: Source date(s): 2024. Indications transcribed from the public NHSA manufacturer submission; this is not verification of the complete current label. Additional indications may be supported by newer announcements or submissions rather than the older full label; see the indication sources.
Prescribing-information limitations: Indications checked against an official public submission. The full original prescribing information is still unavailable.
China availability status: Historical Chinese approval verified; current continuous market availability has not been checked for every product.
Overseas status: Market-by-market verification pending.
Insurance classification: Included in national insurance (Category B)
Insurance edition: 2025 edition; effective 1 January 2026
Insurance restrictions: No additional restriction is specified for this formulary entry. General formulary rules and legally approved indications still apply.
Insurance period: 2025-01-01 to 2026-12-31
Insurance verification notes: Matched by exact or normalized ingredient/formulation name. Reimbursement still depends on the dosage form and listed payment restrictions.

Sources

Open the interactive record, public price references and discussions